eli lilly hims - Search News

News

Lilly soars

Eli Lilly stock spikes as efficacy of new weight-loss pill rivals Ozempic

The company's breakthrough puts the market one step closer to having an injection-free alternative for the treatment of obesity and diabetes.

The Detroit News · 16h

Lilly soars after weight-loss pill results rival Ozempic’s

Eli Lilly and Co. shares surged after data showed its experimental weight-loss pill worked as well as the Ozempic shot.

The New York Times · 15h

What to Know About Eli Lilly’s Daily Pill for Weight Loss

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat obesity and diabetes.

19hon MSN

Why Eli Lilly Stock Is Soaring Today, While Novo Nordisk and Viking Therapeutics Slide

Lilly shares are up 14.2% in response to the news, while shares of its rivals in the GLP-1 weight loss market, Novo Nordisk ( ...

HIMS Stock: Time For A Turnaround?

HIMS has experienced similar dramatic drops before. During the 2022 inflation surge, the stock fell 87%, and in 2020, it ...

Modern Healthcare7d

Inside Eli Lilly’s digital health strategy for GLP-1s

Eli Lilly's foray into telehealth shows the emerging importance virtual care platforms are playing in the rising popularity ...

Nasdaq8d

Hims’ Weight Loss Expansion: Real Growth or Just Hype?

In a short but sweet press release, Eli Lilly greatly diminished the enthusiasm that Zepbound would drive growth for Hims. It stated simply that “Eli Lilly and Company has no affiliation ...

Pharmaceutical Technology on MSN20h

The GLP-1 drug shortage is over. What’s next for the compounders?

Telehealth providers, whose revenue skyrocketed amidst GLP-1 shortages, remain defiant on their compounded semaglutide ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results